跳至主要内容
临床试验/ACTRN12608000128392
ACTRN12608000128392已完成未知

Effectiveness of modafinil in improving deficits of daytime sleepiness in a randomised crossover trial in mild to moderate obstructive sleep apnea patients.

Woolcock Institute of Medical Research0 个研究点目标入组 32 人开始时间: 2008年3月11日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
Male

入选标准

  • Patients must be aged 18 to 70, diagnosed obstructive sleep apnea by night polysomnography (apnea-Hypopnea Index =5, = 30), refuse or cannot tolerate a continuous positive airway pressure device and/or a mandibular advancement splint and Epworth Sleepiness Score = 10.

排除标准

  • Patients will be excluded if they are suffering from any uncontrolled concurrent medical or psychiatric illness or if they are currently taking any medications that are known to affect sleep, or that may cause a drug interaction with modafinil; has medical conditions that would contraindicate administration of modafinil (eg, major anxiety, unstable hypertension, coronary artery disease) or has irregular sleep patterns, such as shift-workers.

研究者

相似试验